Ozanimod Therapy in a Patient With Ulcerative Colitis and Multiple Sclerosis: Hitting 2 Birds With 1 Stone.

Vuyyuru, Sudheer K; Morrow, Sarah A; Jairath, Vipul

Vuyyuru, Sudheer K; Morrow, Sarah A; Jairath, Vipul.

Afiliação

Vuyyuru SK; Department of Medicine, Division of Gastroenterology, Schulich School of Medicine, Western University, London, Ontario, Canada.
Morrow SA; Department of Clinical Neurological Sciences, Schulich School of Medicine, Western University, London, Ontario, Canada.
Jairath V; Department of Medicine, Division of Gastroenterology, Schulich School of Medicine, Western University, London, Ontario, Canada.

ACG Case Rep J ; 10(1): e00955, 2023 Jan.

Article em En | MEDLINE | ID: mdl-36699181

ABSTRACT

ABSTRACT

Simultaneous occurrence of multiple sclerosis (MS) and ulcerative colitis (UC) is seldom encountered by clinicians and poses unique challenges. The sphingosine-1-phosphate receptor modulator ozanimod has been recently approved for UC. Ozanimod can be used in such scenarios where it can treat both conditions, reducing the need for multiple targeted therapies. We report the first case of successfully treated multiple sclerosis and UC with ozanimod.

Palavras-chave

multiple sclerosis; oral small molecules; ulcerative colitis

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: ACG Case Rep J Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Canadá

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google